Recently, a new sequence type, ST730, from an OXA-23-producing *Acinetobacter baumannii* has been deposited in the multilocus sequence typing (MLST) database (http://www.pasteur.fr) ([@B8]). In the present study, we describe two isolates of *A. baumannii* ST730 carrying the *bla* ~OXA-72~ gene from different patients in a hospital located in southern Brazil.

In March 2013, a carbapenem-resistant *Acinetobacter* sp. was isolated using VITEK^®^2 system (bioMérieux, La Balme-les-Grottes, France) from the tracheal aspirate (\> 10^6^ CFU/mL) of a 76-year-old female ICU patient in a 312-bed tertiary care hospital in Porto Alegre, southern Brazil. A few days later, another carbapenem-resistance in *Acinetobacter* sp. was reported from a blood culture (positive in 12 h) of an 86-year-old male ICU patient admitted with sepsis in the same hospital. Both the isolates were identified as *A. baumannii* by matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF; Bruker Daltonik, Bremen, Germany) spectrometry and *gyrB* multiplex polymerase chain reaction (PCR). Disc-diffusion assays demonstrated that the isolates were resistant to meropenem, imipenem, amikacin, ampicillin-sulbactam, cefepime and ceftazidime. However, the isolates were found to be susceptible to polymyxin (MICs 1 and 2 µg/mL) and tigecycline (MICs 0.5 and 0.75 µg/mL) as per microdilution and Etest^®^ assays, respectively. The results obtained were interpreted according to the CLSI guidelines (CLSI 2014). The carbapenemase genes (*bla* ~OXA-23-like~, *bla* ~OXA-24/40-like~, *bla* ~OXA-58-like~ and *bla* ~OXA-143-like~) were investigated by multiplex PCR as previously described ([@B6]. The *bla* ~OXA-24/40-like~ gene was detected in both the isolates. Sequencing of *bla* ~OXA-24~ gene (ABI 3500 Genetic Analyzer; Applied Biosystems, Foster City, CA, United States) identified the variant *bla* ~OXA-72~, which displayed 100% identity to the original *bla* ~OXA-72~ gene (GenBank accession number AY739646.1). Clonal diversity, investigated by repetitive-sequence-based PCR (REP-PCR), revealed an identical profile of the isolates ([@B2]. MLST was performed according to the Institut Pasteur scheme (http://www.pasteur.fr) and both the isolates were identified as ST730.

Resistance to carbapenems among *A. baumannii* isolates from Brazil has been mostly related to the production of OXA-23, followed by OXA-143 ([@B8]). In fact, OXA-72-producing *A. baumannii* isolates are still uncommon in Brazil. The first two cases of *A. baumannii* carrying *bla* ~OXA-72~ gene were reported from São Paulo (Southeast Brazil) in 2011 ([@B1], [@B9]). Two years later, this gene was reported in two other *A. baumannii* isolates from Recife (Northeast Brazil) ([@B3]). Recently, a surveillance study evaluated nine hospitals from five different states, representative of all the Brazilian regions, and described an inter-hospital dissemination of 10 *A. baumannii* isolates containing *bla* ~OXA-72~ in São Paulo ([@B8]). These data highlight the possibility of the spread of this gene in the country. Furthermore ([@B9]), reported the presence of *bla*OXA-72 gene inserted on a plasmid of \~ 86 kb, highlighting its potential for spread.

Here, we describe, for the first time, two *A. baumannii* isolates harbouring the *bla* ~OXA-72~ gene isolated from Rio Grande do Sul, southern Brazil. These data point towards the increasing diversity of oxacillinases among the clinical isolates of *Acinetobacter* spp. in Brazil. Recently, Cayô et al. (2015) deposited an OXA-23-producing isolate, *A. baumannii* ST730, in the Institut Pasteur database. ST730 is a single-locus variation of ST79 (CC79), responsible for the spread of *bla* ~OXA-23~ in Latin America ([@B4], [@B8]). It is worrisome that the emergent OXA-72-producing clones share the same phylogenetic origin with the clones harbouring *bla* ~OXA-23~ gene, since the latter demonstrated a remarkable capacity of dissemination and maintenance along the years in Brazilian hospitals ([@B7]). The results presented in this study highlight the importance of monitoring the spread of successful clones associated with the dissemination of *A. baumannii* carrying *bla*OXA in Brazil by molecular epidemiology methods such as MLST.
